文献速递慢阻肺

年轻人早期慢阻肺对临床慢阻肺发展的重要性:哥本哈根一般人群研究

Importance of Early COPD in Young Adults for Development of Clinical COPD: Findings from the Copenhagen General Population Study.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01

本研究基于哥本哈根一般人群研究,纳入14,870名20-100岁个体,间隔10年进行肺功能检查。早期慢阻肺定义为年龄<50岁且基线FEV1/FVC低于正常下限。结果显示,在吸烟≥10包年的吸烟者中,有早期慢阻肺者10年后24%发展为临床慢阻肺,而无早期慢阻肺者仅4%;早期慢阻肺者临床慢阻肺风险显著增高(OR 7.77),急性加重住院风险也增高(HR 4.16)。结论提示应根据吸烟暴露量重新考虑早期慢阻肺的定义阈值。

要点

  • 年轻成人早期慢阻肺(FEV1/FVC<LLN)10年后临床慢阻肺风险显著增加。
  • 吸烟≥10包年者中,早期慢阻肺者24%进展为临床慢阻肺,无早期慢阻肺者仅4%。
  • 早期慢阻肺者急性加重住院风险增高(HR 4.16)。

核心结论

  • 在一般人群中,年轻成人早期慢阻肺患者10年后进展为临床慢阻肺的比例取决于吸烟暴露量,最高不足24%。
  • 吸烟暴露阈值用于定义早期慢阻肺可能需要重新考虑,因为年轻个体在高吸烟暴露者中代表性不足。

研究设计与样本

  • 基于哥本哈根一般人群研究的队列分析,纳入14,870名20-100岁个体,间隔10年进行肺功能检查。
  • 早期慢阻肺定义为年龄<50岁且基线FEV1/FVC低于正常下限。
  • 主要结局为10年后临床慢阻肺(慢性呼吸道症状伴FEV1/FVC<0.70且FEV1<80%预计值)及随访期间急性加重住院。

主要发现

  • 在基线年龄<50岁且FEV1/FVC≥0.70的5,497名个体中,104名(3%)10年后发展为临床慢阻肺。
  • 吸烟≥10包年的吸烟者中,4%有早期慢阻肺;吸烟<10包年者中3%有早期慢阻肺;从不吸烟者中2%有早期慢阻肺。
  • 吸烟≥10包年者中,有早期慢阻肺者24%发展为临床慢阻肺,无早期慢阻肺者4%发展;吸烟<10包年者中分别为10%和1%;从不吸烟者中分别为3%和<1%。
  • 有早期慢阻肺者10年后临床慢阻肺的OR在吸烟≥10包年者为7.77(95%CI 4.10-14.7),在所有吸烟者中为8.56(95%CI 4.92-14.9)。
  • 有早期慢阻肺者急性加重住院的HR在吸烟≥10包年者为4.16(95%CI 1.66-10.5),在所有吸烟者中为4.33(95%CI 1.89-9.93)。

关键数值与推荐

  • 早期慢阻肺定义:年龄<50岁且FEV1/FVC低于正常下限。
  • 临床慢阻肺定义:慢性呼吸道症状伴FEV1/FVC<0.70且FEV1<80%预计值。

临床怎么用

  • 对于年轻成人,尤其吸烟者,应关注早期慢阻肺的识别,因其10年后临床慢阻肺及急性加重住院风险显著增高。
  • 吸烟暴露量应纳入早期慢阻肺风险评估,低吸烟暴露的年轻个体也可能发生早期慢阻肺并进展。

局限性

  • 研究结果基于哥本哈根一般人群研究,外部推广需谨慎。
  • 早期慢阻肺定义基于FEV1/FVC低于正常下限,不同参考方程可能影响结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Individuals who will develop chronic obstructive pulmonary disease (COPD) could be identified at an early age before clinical manifestations appear. Objectives: We investigated risk of clinical COPD 10 years later in young adults from the general population with and without early COPD with a focus on smoking exposure. Methods: We included 14,870 individuals aged 20-100 years from the Copenhagen General Population Study with spirometry 10 years apart. Early COPD was defined as baseline FEV1/FVC less than the lower limit of normal in individuals aged <50 years. Outcomes included clinical COPD at final examination 10 years later (chronic respiratory symptoms with FEV1/FVC <0.70 and FEV1 <80% predicted) and acute exacerbation hospitalizations during follow-up. Measurements and Main Results: Among 5,497 individuals aged <50 years at baseline with FEV1/FVC ≥0.70, 104 (3%) developed clinical COPD 10 years later; 4% of smokers with ≥10 pack-years had early COPD; 3% of smokers with <10 pack-years had early COPD; and 2% of never-smokers had early COPD. Among smokers with ≥10 pack-years, 24% developed clinical COPD in those with early COPD versus 4% in those without early COPD. Corresponding numbers were 10% and 1% in smokers with <10 pack-years and 3% and <1% in never-smokers, respectively. Among individuals with early COPD, odds ratios for clinical COPD 10 years later were 7.77 (95% confidence interval [CI], 4.10-14.7) in smokers with ≥10 pack-years and 8.56 (95% CI, 4.92-14.9) in all smokers, whereas hazard ratios for acute exacerbation hospitalizations were 4.16 (95% CI, 1.66-10.5) and 4.33 (95% CI, 1.89-9.93), respectively. Results were validated in the Copenhagen City Heart Study. Conclusions: Depending on amount of smoking exposure, <24% of young adults in the general population with early COPD develop clinical COPD 10 years later. A smoking exposure threshold for early COPD should be reconsidered, as younger individuals are less represented in those with high smoking exposure.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Çolak Y, Afzal S, Nordestgaard BG, et al. Importance of Early COPD in Young Adults for Development of Clinical COPD: Findings from the Copenhagen General Population Study. Am J Respir Crit Care Med. 2021. PMID: 33142077. doi:10.1164/rccm.202003-0532OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。